| 1 day | +3.13% |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gerckens
CEO | Chief Executive Officer | 39 | 2024-12-31 |
Michael Rudolf
DFI | Director of Finance/CFO | 52 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Clemens Fischer
CHM | Chairman | 51 | 2020-03-03 |
| Director/Board Member | 45 | 2020-03-03 | |
Axel Rebien
BRD | Director/Board Member | 55 | 2020-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-08-13 | Sell | Chairman | 1,315 | 0.0110% | ||
| 25-08-10 | Sell | Chairman | 39,678 | 0.3306% | ||
| 25-08-07 | Sell | Chairman | 873 | 0.0073% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.13% | +3.13% | - | - | 447M | ||
| +0.35% | -4.87% | +49.87% | +157.34% | 1,031B | ||
| -2.69% | -6.22% | +59.19% | +54.51% | 595B | ||
| -0.27% | -3.41% | +30.97% | +79.48% | 431B | ||
| -0.74% | -2.44% | +27.75% | +22.04% | 326B | ||
| -0.40% | -2.24% | +27.75% | +43.10% | 277B | ||
| -0.84% | -6.71% | +19.38% | +22.14% | 263B | ||
| +0.51% | +3.26% | -23.75% | -38.32% | 224B | ||
| +0.86% | -2.63% | +22.50% | +57.55% | 193B | ||
| +1.28% | -3.03% | +20.76% | +70.62% | 164B | ||
| Average | +0.70% | -3.79% | +26.05% | +52.05% | 389.37B | |
| Weighted average by Cap. | +0.72% | -4.31% | +35.46% | +76.48% |
Employees
98
Sector
Pharmaceuticals
















